chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Individual stated she was feeling pressure on left lateral neck and left forearm. Diaphoretic, pale and almost fainted. Given 200mg Motrin and recovered.
Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Heavy sweats after going to bed; Arm was sore/ Arm is tender; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Heavy sweats after going to bed), PAIN IN EXTREMITY (Arm was sore/ Arm is tender), PYREXIA (Fever) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore/ Arm is tender), PYREXIA (Fever) and CHILLS (Chills). On 30-Mar-2021, the patient experienced HYPERHIDROSIS (Heavy sweats after going to bed). At the time of the report, HYPERHIDROSIS (Heavy sweats after going to bed), PAIN IN EXTREMITY (Arm was sore/ Arm is tender), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
within 30 seconds of injection the following symptoms were experienced: flushing, headache (still experiencing), nausa, weakness,chills, tightness of throat--felt like it was closing,feelings of fainting, weakness, loss of appetite, diarrhea after 32 hours, joint pain
Hives, difficulty speaking, mild respiratory distress. Patient given O2, diphenhydramine, epinephrine and SOLU-MEDROL. Patient stabilized. Diphenhydramine-50mg IV, SOLU-MEDROL 125mg IV, Epinephrine 0.5mg IM.
Redness, warmth, swelling to left upper arm/shoulder area the morning after vaccine. Treated with antibiotics for possible cellulitis.
Pediatric patient was inadvertently given adult dose of Hep A.  Error was noticed right away, mom was notified and site was consulted as well as the nurse on duty.  The website advised to monitor the child, the dose given counts as dose #1 and does not affect the timing on dose #2.  Mom called 2 days later  (7/28/22) and reported diarrhea and some crankiness. Nurse advised BRAT diet for diarrhea, and continue monitoring.
Started within 6 hours of injection. Started with sore arm and then sore neck on same side. Continued to fever, chills, headache, body ache, fever, nausea and vomiting
26 & 27FEB fever of 103 ax given APAP; 28FEB seen by MD for fever, anorexia, raspy breathing; 29FEB hospitalized fever of 101.8; pt given ATB x 2 days; no sz or convuls;
Extremely High Fever, Chills, Urination burning, Nausea, Headache, Sore Throat, Extreme Fatigue, Mental fog and unusual thoughts.
Aches, nausea, dizziness, chills lasting 24 hours 3 days later, symptoms all resolved, except that tenderness persists around vaccination site
102.7 degree temperature on 7/20 he rec'd MMR and Chicken Pox Vaccines on 7/16
slight back pain; sore neck; nausea; dizzy; neck pain; abdominal pain; felt weak; Headache; Muscle pain; Fever; Back injury; blood pressure was high(195/100); Chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain) and ABDOMINAL PAIN (abdominal pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever). On 01-Mar-2021, the patient experienced DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak) and NAUSEA (nausea). On 04-Mar-2021, the patient experienced BACK PAIN (slight back pain) and NECK PAIN (sore neck). On 26-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak), BACK PAIN (slight back pain), NECK PAIN (sore neck), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement: 195/100 mmHg (High) 195/100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Patient received Moderna Vaccine on 10/5/2021. The shelf life expired on 10/3/2021. The vaccine expiration date is 10/10/2021.
Rushed by ambulance for chest pain, ddimer showed very elevated. Patient was administered fetynol and other stuff. Patient broke out in hives was given bendryl. Patient gotten first vaccination that day. Within a week patient started passing very large clots from menstruating, was given uterine oblation to solve large fibroids and clots, patients procedure was a fail and continues to have infections and now has sever allergies to antibiotcs, never had allergies before. Was prescribed prednisone and benadryl for hives that lasted 5 days. Taken off all antibiotics, preparing for hysterectomy.
Information has been received from a female clinic employee concerning her daughter who in approximately July 2008, was vaccinated with a dose of GARDASIL (lot# not reported) and a dose of tetanus toxoid (lot# and manufacturer unknown). In approximately July 2008, the patient developed a 105 degree Fahrenheit fever and a bad headache within 30 minutes following the vaccinations. The fever and headache lasted a few hours and the patient consulted a physician via phone call, who instructed her to manage the fever with TYLENOL and ice packs. At the time of this report, the patient had fully recovered. No further information is available.
Fever,chills, cough,muscle aches,phlegm,nausea.
The next day on 07Apr21 my daughter started having syncope episodes. They have gotten increasingly worse since then; This is a spontaneous report from a contactable consumer (parent). A 16-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as dose 1, single; then dose 2 via an unspecified route of administration, administered in Arm Left on unspecified date (Batch/Lot number was not reported) as dose 2, single (at the age of 16 years) for covid-19 immunisation. The patient's medical history included covid-19 (prior to vaccination)from an unknown date and unknown if ongoing. Concomitant medications included lurasidone hydrochloride (LATUDA); omeprazole (OMEPRAZOLE); propranolol (PROPANOLOL [PROPRANOLOL]); riboflavin (RIBOFLAVIN); magnesium oxide (MAGNESIUM OXIDE); trazodone (TRAZODONE); ethinylestradiol, norethisterone acetate (LOESTRIN), all were taken for an unspecified indication, start and stop date were not reported. The patient previously took keppra [levetiracetam] and amoxicillin and had allergies (known allergies to Keppra and amoxicillin). The patient experienced the next day (reported as 07Apr21) patient started having syncope episodes, they have gotten increasingly worse since then on unspecified date in 2021. It was reported that the patient was hospitalized for 3 days due to the event. It was also reported that the event resulted to doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the event was not recovered. The patient was not tested for Covid-19 post vaccination.    The lot number for vaccine [BNT162B2], was not provided and will be requested during follow-up.
Patient received 50 mcg Moderna COVID-19 vaccine instead of recommended 100 mcg.
Information has been received from an office manager concerning a 73 year old patient (gender not reported) who on 20-NOV-2007 was vaccinated (route and site not reported) with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (Lot#655765/1229F). Post vaccination, the patient developed redness on the upper arm, burning, severe pain and hot sensation. It is unknown if the patient received medical attention and if the patient recovered. This is one of 2 reports with the same source. Additional information has been requested.
Swelling at the site of injection. It took about 10 seconds to swell came out to be size of half golf ball
SUMMARY OF PATIENT PROGRESS:   STATUS: Progressing as expected towards goals - continuing present plan   Primary Problem: COVID    Key findings related to primary problem: Patient A&O x 4. Tele and vital signs monitored. No signs of respiratory distress noted. Patient denied any pain. Ambulation in room done with moderate fatigue. Patient up to chair. Patient tolerating diet. Patient encouraged to shift weight frequently to maintain skin integrity.    Other key findings: none at this time.          Note Details  Author  (R.N.) File Time 9/11/2023  2:47 PM Author Type REGISTERED NURSE Status Signed Last Editor  (R.N.) Specialty GENERAL, OTHER Hospital Acct #  Admit Date 9/8/2023  ED to Hosp-Admission (Discharged) on 9/8/2023  ED to Hosp-Admission (Discharged) on 9/8/2023   Detailed Report  Note shared with patient Care Timeline  09/09   Transferred to ICU 1210   Admitted from ED (Observation) 1210 09/10   Transferred out of ICU 1800 09/11   Discharged 2005
In addition to typical, previously reported side effects, i.e. pain at injection site, exhaustion, general malaise. I also experienced acute memory loss, I can remember events at 4 PM on day of injection but nothing until the next morning, and I have inflammation and swelling at my left knee, likely pre-patellar bursitis. There is no history of either moderate side effect. There is no obvious explanation (e.g. a fall) that explains the knee bursitis.
On Sep 20, 2021 received blood reports back of anemia. No history of anemia in family and all previous annual blood tests never showed this before. Currently on medication under supervision of primary care physician in Block 14. Symptoms began sometime during the summer (the date in Block 5 is an estimate). Started experiencing lethargy (not sure if related, but this was a similar feeling I had a day or two after the vaccine). I'd get tired much quicker and winded much faster than ever before. No significant changes to diet or lifestyle before during or after vaccination date in block 4.
The pt's right upper arm was red, itchy and warm to touch, immediately after flu injection, 9" X 13". Temperature was 98.8F.
This spontaneous case, initially received from a pharmacist on 31-Oct-2018, concerns a 65-year-old, elderly female patient. On 13-Oct-2018, the patient was administered FLUAD TIV [dose: 0.5 ml, route of administration; intramuscular, anatomical location: deltoid, batch number and expiry date: not reported]. On the same day after vaccination, the patient experienced chills and cold sweats which lasted for about 2 minutes. The next morning (14-Oct-2018), the patient woke up with stiffness in her fingers/hands and was hard to bend her fingers. On an unspecified date in Oct-2018 (reported as lasted 1 week), the patient had recovered from the event fingers stiffness. The reporter assessed the case as non-serious.
Information has been received from a licensed practical nurse referring to multiple unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with doses of M-M-R II (lot # L024268, expiration date: 01-JUL-2017; route not reported) that were improperly stored (0.6 degree C for 11 hours and 10 minutes and 12.3 degree C for 50 minutes; data logger). No adverse effects were reported. This is the several reports from the same reporter. Additional information has been requested.
pronounced heart beat especially when leaning back on hard surface or lying down on my back. Also, daily mild dizziness. They both started just after second vaccination shot.
had a headache and felt generally fatigued and congested starting 11pm on the day I received the vaccine through the following evening.  took tylenol twice during that period and was perfectly fine the following day (about a day and a half after receiving vaccine).
Patient received flu shot on 9/24/13. On Friday 9/26/14 she was treated for cellulitis.
Child had 15 months well exam. He also has allergies. Received PENTACEL. 30 min. after allergic reaction seen by urgent care.
This spontaneous report was received from a consumer regarding her daughter, a female patient of unknown age. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The reported stated that her daughter received dose two of GARDASIL about two to three years after the first dose. No adverse events reported. Additional information has been requested.
Developed an asthma attack within 1.5-2 hours of vaccination alleviated by dulera steroid inhaler and albuterol HFA inhaler. Had coughing, Shortness of breath, and wheezing which was alleviated with medications. Asthma attack lasted about 30-45 minutes and then improved with medications.  - About 48 hours developed a headache left sided aching which has been present since the vaccination (2 months ago), comes and goes, but has been present every week since vaccination.  - 1 week after vaccination developed severe fatigue and vitiligo on bilateral arms and right lower leg. Vitiligo still present and worsening.
Information has been received from a consumer concerning her 21 year old daughter female with dysmenorrhea and no drug reactions or allergies who on 08-JUN-2007 (also reported as 18-JUN-2007), later in 2007 and on 08-JAN-2008 was vaccinated with the first, second and third dose of HPV vaccine (doses, routes and lot # were no reported), respectively. It was reported that about one week ago, in approximately 06-JAN-2012, the patient was tested positive for having human papillomavirus (HPV) strain 16 and 18 (determined by DNA test). It was noted that the consumer want to know why the vaccine did not work. It was reported that PAP smear was done by the physician and stated the result. The consumer mentioned that to saw the level and intensity of the strain, the physician did a colposcopy to investigate further and discover the severity (results not provided). Patient sought medical attention by visiting the physician's office. At the time of the report, the patient was recovering (also reported as AE did not improved). Follow up information has been received from the physician concerning a female patient who on 18-JUN-2007, was intramuscularly vaccinated with the first dose of dose of HPV vaccine (lot # 654535/0960F, dose not reported) in to left deltoid, on 17-AUG-2007, the patient was intramuscularly vaccinated with the second dose of HPV vaccine (lot # 658282/0929U, dose not reported) in to left deltoid and on 08-JAN-2008, the patient was vaccinated with the third dose of HPV vaccine (dose, route and lot number were not reported). Concomitant therapy included hepatitis a vaccine, VAQTA administered intramuscularly on 18-JUN-2007 (lot # 657305/0247U, dose was not reported), in to right deltoid and MENACTRA. The physician reported that no adverse event occurred with vaccine administration. Additional information has been requested. This is a corrected report. Hepatitis a vaccine, VAQTA was changed from a suspect to a concomitant product.
developed high fever; Chills; Headache; This is a spontaneous report from a contactable consumer via Medical information team. A female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: Unknown), via an unspecified route of administration on 14Apr2021 as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Daughter, calling on behalf of mother reported that the patient received her first dose on 14Apr2021 (yesterday) and now developed high fever, chills and headache on an unspecified date in Apr2021. She wanted to know whether she can take any medicine and was waiting for doctor to call her back. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a Medical Assistant refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. From 25-OCT-2017 through 07-NOV-2017,  the patient was vaccinated with improperly stored dose of ROTATEQ orally, lot # N000175, expiration date 20-SEP-2018 (dose was not reported) for prophylaxis. No adverse effects were reported. The temperature involved was 35 degrees Fahrenheit for 16 hours. There was no previous temperature reported, and a data logger was not involved.; Sender's Comments: US-009507513-1711USA010360: Original Case : 1711USA003934 US-009507513-1711USA003934: Original Case: 1711USA003934.
At injection site, pt had a red, swollen knot. The size was (> quarter). It was feverish and very tender.
Rash; Itchy; Warm to touch; Vaccine administered at inappropriate site as an event; This case was reported by a pharmacist via call center representative and described the occurrence of red rash in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 23JK5, expiry date 13th April 2020) for prophylaxis.   On 9th June 2019, the patient received the 1st dose of Shingrix. In June 2019, less than a week after receiving Shingrix, the patient experienced red rash, itchy rash, skin warm and vaccine administered at inappropriate site. On an unknown date, the outcome of the red rash, itchy rash, skin warm and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the red rash, itchy rash and skin warm to be related to Shingrix.  Additional details were provided as follows: The health care professional stated that the patient received Shingrix Injection administered on patient's back side of arm.  The front side had redness covering the whole bicep. The health care professional described it looked like a rash, warm to touch, little itchy, 4 inches long and 3 inches wide.  Pharmacist asked any information on Shingrix reaction on the opposite side of the arm.
PATIENT STATES SHE IS STILL EXPERIENCING NAUSEA AND HEADACHES FROM 1ST COVID SHOT. ADVISED PATIENT TO TAKE ZOFRAN AND/OR TYLENOL BUT TO CONTACT MD IF SYMPTOMS PERSIT.
vice tightening headache; headaches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), FATIGUE (fatigue) and HEADACHE (vice tightening headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 98B21A and 010A21A) for COVID-19 vaccination.     The patient's past medical history included GERD. Concurrent medical conditions included Allergy to antibiotic (Doxycycline), Drug allergy (Bactrim), Drug allergy (Prilosec), Drug allergy (Prometrium), Environmental allergy, Asthma (Increased shortness of breath) since 2002 and Arthritis (Increased joint inflammation and pain). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, FAMOTIDINE for GERD, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID], ZINC and CALCIUM for an unknown indication.   On 04-Mar-2021 at 10:05 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021 at 10:05 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced HEADACHE (headaches) and FATIGUE (fatigue). On 09-Apr-2021, the patient experienced HEADACHE (vice tightening headache). On 11-Apr-2021, HEADACHE (vice tightening headache) had resolved. At the time of the report, HEADACHE (headaches) and FATIGUE (fatigue) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No treatment medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077962 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Reporter's address, Patient's details, Patient' past medical history, Suspect product details, Concomitant medication were added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077962:MOD-2021-077962 (Case for dose 1)
Patient prior to vaccine had complete remission of her chronic idiopathic urticaria and angioedema on omalizumab and was tapering off of omalizumab after being able to taper most of her other anti-urticarial medication and had been urticaria free for over 2 years.  On the morning of 19 March 2021, 2 days after the second pfizer covid vaccine she had returen of her urticaria and angioedema that were significant and widespread and have remained difficult to control despite returning to full dose monthly omalizumab for 3 months and resuming her ceteriziine, famotidine, montelukast, as needed benadryl and at least one limited course of prednisone.
Mental status changed: pt became confused, disorientated and developed delirium symptoms that required hospitalization.
After 3 days patient had low energy and did not feel well.  Three days after the high fever started and had problems breathing.   The progression was slow.  After 4 days took went to doctor for fever. Doctor noticed red spots in mouth and specified it might be virus related. Blood results were negative.   Symptoms continued and school kept calling specifying patient was sick.  Patient went to doctor again with same symptoms; the chest X-rays were negative. Patient had problems breathing again so went to the doctor and diagnosed with bronchitis. Patient prescribed antibiotics and nebulizer to help with breathing. Patient's symptoms improved a little with medicine.   In December patient had one doctor visit and directed to continue with nebulizer.  The last doctor visit was 3 days ago and per doctor, it might be asthma.  Patient has problems breathing every time he runs.  Patient is not sure if patient continues to have bronchitis or asthma.  Patient was healthy before vaccine.
1 1/2hr p/vax t101, irritable, vomiting & diarrhea later in the evening, leg sore, swollen, won't straighten leg;